C12Y504/99039

METABOLIC ENGINEERING
20230279444 · 2023-09-07 ·

The invention relates generally to materials and methods for biosynthesising quillaic acid in a host by expressing heterologous nucleotide sequences in the host each of which encodes a polypeptide which in combination have said QA biosynthesis activity. Example polypeptides include (i) a Beta-amyrin synthase; (ii) an enzyme capable of oxidising Beta-amyrin or an oxidised derivative thereof at the C-28 position to a carboxylic acid; (iii) an enzyme capable of oxidising Beta-amyrin or an oxidised derivative thereof at the C-16a position to an alcohol; and (iv) an enzyme capable of oxidising Beta-amyrin or an oxidised derivative thereof at the C-23 position to an aldehyde. Preferred nucleotide sequences are obtained from, or derived from, Q. saponaria.

Triterpene Production

An engineered microbial cell expressing a β-amyrin synthase, a cytochrome P450 reductase, a cytochrome P450 C28 oxidase, a cytochrome P450 C16 oxidase and a cytochrome C23 oxidase is used to make quillaic acid from β-amyrin.

Saponin production in yeast

The present invention relates inter alia to methods of biosynthetic production of QS-21, precursors and variants thereof, and to related aspects.

Metabolic engineering
12391963 · 2025-08-19 · ·

The invention relates generally to materials and methods for biosynthesising quillaic acid in a host by expressing heterologous nucleotide sequences in the host each of which encodes a polypeptide which in combination have said QA biosynthesis activity. Example polypeptides include (i) a Beta-amyrin synthase; (ii) an enzyme capable of oxidising Beta-amyrin or an oxidised derivative thereof at the C-28 position to a carboxylic acid; (iii) an enzyme capable of oxidising Beta-amyrin or an oxidised derivative thereof at the C-16 position to an alcohol; and (iv) an enzyme capable of oxidising Beta-amyrin or an oxidised derivative thereof at the C-23 position to an aldehyde. Preferred nucleotide sequences are obtained from, or derived from, Q. saponaria.

SAPONARIOSIDE BIOSYNTHETIC ENZYMES
20250346914 · 2025-11-13 ·

This invention relates to methods of producing triterpenoids using one or more of (i) Saponaria officinalis -amyrin synthase (SobAS) (ii) S. officinalis C28 oxidase (SoC28) (iii) S. officinalis C28C16 oxidase (SoC28C16)(iv) S. officinalis C23 oxidase (SoC23); (v) S. officinalis QA 3-O glucuronosyl transferase SoCSL; (vi) S. officinalis QA-GlcA SoC3Gal; (vii) S. officinalis QA-GlcA-Gal x SoC3Xy; (vii) S. officinalis QA-Tri fucosyl transferase SoC28Fu (ix) S. officinalis QA-TriF rhamnosyl transferase SoC28Rha (x) S. officinalis QA-TriFR xyl SoC28Xul1; (xi) S. officinalis QA-TriFRX xyl SoC28Xyl2; (xii) S. officinalis QA-TriFRXX quinovosyl SoGH1 and (xiii) A. officinalis QA-TroF(Q)RXX acetyl SoBAHD1 polypeptide. Methods, host cells, isolated polypeptides, nucleic acids, and plants are provided.